Perhaps B's designation on this board as a super/wonder drug is premature. If it's so great and all this news is major, then why does the company continually post this "plea" in numerous press releases -
"For researchers and institutions interested in collaborating on Brilacidin for COVID-19, please send inquiries to: covid19@ipharminc.com"
April, 20, April 27, May 5, May 19, June 11, June 17, July 20, August 4...Leo has been looking for collaborators since April and apparently nobody has stepped up. Why?